bathocuproine disulfonate has been researched along with homocysteine in 2 studies
| Studies (bathocuproine disulfonate) | Trials (bathocuproine disulfonate) | Recent Studies (post-2010) (bathocuproine disulfonate) | Studies (homocysteine) | Trials (homocysteine) | Recent Studies (post-2010) (homocysteine) |
|---|---|---|---|---|---|
| 103 | 0 | 25 | 15,871 | 1,348 | 5,010 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andersson, A; Hultberg, B; Isaksson, A | 1 |
| Exner, M; Gmeiner, B; Hartmann, B; Hermann, M; Hofbauer, R; Kapiotis, S | 1 |
2 other study(ies) available for bathocuproine disulfonate and homocysteine
| Article | Year |
|---|---|
Thiol redox status influences extracellular concentration of homocysteine in HeLa cell cultures.
Topics: Acetylcysteine; Copper; Dithiothreitol; Dose-Response Relationship, Drug; HeLa Cells; Homocysteine; Humans; Indicators and Reagents; Ions; Oxidation-Reduction; Oxygen; Phenanthrolines; Sulfhydryl Compounds | 2000 |
Homocysteine promotes the LDL oxidase activity of ceruloplasmin.
Topics: Ceruloplasmin; Copper; Cysteine; Homocysteine; Humans; Indicators and Reagents; Lipoproteins, HDL; Lipoproteins, LDL; Methionine; Oxidation-Reduction; Phenanthrolines | 2002 |